Success Story: Thanks to Our Expert Filing, an EB-1A Petition for a Neuroscience Expert Was Approved in Just 6 Days Under Premium Processing
Client’s Testimonial:
"I'm grateful for WeGreened's experience navigating the legal process and guiding me through case preparation. Their advice on how to best prepare and present evidence to meet the criteria of "original contributions of major significance" was particularly helpful in strengthening my application.”
On May 28th, 2026, we received another EB-1A (Alien of Extraordinary Ability) approval for a Scientist in the Field of Neuroscience (Approval Notice).
General Field: Neuroscience
Position at the Time of Case Filing: Scientist
Country of Origin: China
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: May 28th, 2026
Processing Time: 6 days (Premium Processing Requested)
Case Summary:
Our firm is pleased to share that we secured I-140 EB-1A approval in just 6 days for a client in the field of neuroscience. The case was filed with premium processing at the time of submission, and the petition presented the client as an established expert in neuroscience.
The client holds a Ph.D. in neurobiology and is currently employed as a full-time scientist in a research institute setting, where the client continues to conduct neurobiology research. This current work builds on the client’s broader record of previous research, which was central to the EB-1A strategy.
Case Summary
The petition demonstrated that the client had risen to the top of the field by showing a consistent pattern of original contributions, independent reliance, peer trust, and sustained recognition. Rather than presenting the client’s metrics as self-evidently sufficient, we explained how an adjudicator could interpret them together as proof of extraordinary ability. The publication record showed sustained scholarly productivity in highly selective neuroscience venues, the citation record reflected broad reliance by researchers around the world, and the peer-review service demonstrated that journals trusted the client’s expertise to evaluate the work of other scientists.
Evidence of Extraordinary Ability
The client’s credentials included the following:
- Ph.D. in neurobiology
- 10 peer-reviewed journal articles, including 2 first-authored articles and 1 co-first-authored article
- 1 conference abstract and 1 first-authored preprint
- 1,118 citations to the client’s neuroscience research
- At least 46 completed peer reviews
- Research fundings support
These credentials were strategically framed as part of a larger evidentiary pattern. The citation count was not treated as a simple number. Instead, the petition highlighted that multiple papers ranked among the most-cited works in neuroscience and behavior for their publication years, showing that the client’s findings had been relied upon at a level well beyond ordinary scholarly attention. The peer-review record was also presented as evidence of peer trust, since journals repeatedly asked the client to assess research quality in the same or related fields.
Expert Endorsements
The petition was supported by 4 recommendation letters from experts in neuroscience, including independent experts who were familiar with the client’s work through the field rather than through personal collaboration. These letters helped corroborate the objective evidence, including the client’s publications, citations, peer-review record, funding support, and recognized influence.
“Based on her outstanding achievements thus far, it is clear that she continues to revolutionize the field through her work, with considerable ramifications for healthcare outcomes in the United States.”
EB-1A Approval and Outlook
By organizing the evidence around original contributions, authorship of scholarly articles, judging the work of others, and the final merits determination, the petition showed that the client met the EB-1A standard for extraordinary ability. The case demonstrated that the client’s work had been widely adopted, cited, and extended by other researchers, and that the client’s current research continues to address important challenges in neuroscience and therapeutic delivery.
We congratulate the client on this I-140 EB-1A approval in just 6 days and wish the client continued success in advancing neuroscience research with meaningful benefits for human health.